Will tyrosine kinase inhibitors be part of the treatment armamentarium for CML in the future?
Expert Opin Pharmacother. 2018 Jan 07;:1-3
Authors: Atallah E, Ritchie E
PMID: 29308683 [PubMed - as supplied by publisher]
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου